EPISODE · May 27, 2026 · 5 MIN
CHMP Pipeline Surge, NICE Threshold Jump, JCA Device Push
Episode 11 — 27 May 2026 EMA's CHMP recommended eight medicines including first-ever PROS treatment while NICE raised cost-effectiveness thresholds to £25,000-35,000 per QALY. The EU's Joint Clinical Assessment framework expands into medical devices with five assessments planned for June 2026. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Embed this episode
Ready to play
CHMP Pipeline Surge, NICE Threshold Jump, JCA Device Push
No transcript for this episode yet
Similar Episodes
No similar episodes found.